Joseph R. Payne, M.D.

Request an appointment

Curriculum Vitae

 

Joseph R. Payne, M.D.

Georgia: 059889

Certification:

Specialty: Dermatology

Certifying Board: American Board of Dermatology

Date Certified: August 2004 (expires 2024)

Hospital Privileges:

Northside Hospital, Atlanta, GA

St. Joseph’s Hospital, Atlanta, GA

Undergraduate Education:

Georgia Institute of Technology

Atlanta, Georgia

Bachelors of Mechanical Engineering with Highest Honor

September 1990 – March 1996

Medical Education:

Duke University School of Medicine

Durham, North Carolina

Doctorate of Medicine

August 1996 – May 2000

Internship:

Duke University Hospital

Durham, North Carolina

Department of Internal Medicine

June 2000 – June 2001

Residency:

The George Washington University Hospital

Washington, District of Columbia

Department of Dermatology

July 2001 – July 2004

Military Service:

United States Navy

November 28, 2001 to present

Current Rank: Lieutenant Commander

Professional Experience:

August, 2007 to present Staff Dermatologist

Dermatology Associates of Atlanta, P.C.

5555 Peachtree Dunwoody Road

Suite 190

Atlanta, GA 30342

January, 2005 to January, 2008 Staff Dermatologist

North Florida Dermatology Associates, P.A.

1551 Riverside Avenue

Jacksonville, FL 32204

August, 2004 to February, 2008 Department Head of Dermatology

Naval Hospital Jacksonville

2080 Child Street

Jacksonville, FL 32214-5000

Memberships:

Diplomate, American Board of Dermatology

Fellow, American Academy of Dermatology

Member, American Society for Dermatologic Surgery

Fellow, American Society for Mohs Surgery

Clinical Research Trials and Publications:

“A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis,” Abbott, 2007.

“A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled Study Comparing 1% Clindamycin/ 5% Benzoyl Peroxide Topical Gel (KV Pharmaceutical Company) to DUAC Topical Gel 1% Clindamycin/ 5% Benzoyl Peroxide (Stiefel) in the Treatment of Moderate to Severe Acne Vulgaris,” KV Pharmaceutical Company, 2007.

“A Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Clinical Equivalence of Generic Metronidazole Gel 1% (TOLMAR Inc.) to METROGEL (metronidazole gel) 1% (Galderma Laboratories, LP) and both Active Treatments to a Vehicle Control in the Treatment of Inflammatory Rosacea Lesions,” TOLMAR Inc., 2007.

“A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multi-Site Clinical Study to Evaluate the Bioequivalence of Calcipotriene Ointment 0.005% (Glenmark Pharmaceuticals) to DOVONEX (calcipotriene ointment) 0.005% (Bristol Meyer Squibb) in patients with Moderate to Severe Plaque Psoriasis,” Glenmark Pharmaceuticals, Inc., 2007.

“A Randomized, Double-Blind, Multiple-Site, Placebo Controlled Study Comparing 1% Clindamycin/ 5% Benzoyl Peroxide Topical Gel (KV Pharmaceutical Company) to Benzaclin Topical Gel 1% Clindamycin/ 5% Benzoyl Peroxide (Dermik) in the Treatment of Moderate to Severe Acne Vulgaris,” KV Pharmaceutical Company, 2007.

“An Open Label, Multi-center, Uncontrolled, Single Group Assessment, Long Term Safety Study of 4% Tradename (Fluorouracil) Cream in Subjects with Actinic Keratosis,” HILL Dermaceuticals, Inc., 2007.

“A Phase III, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 4-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of Clindaben (1/2.5), Clindaben Vehicle, Clindamycin (1%), and Benzoyl Peroxide (2.5%) Gels in the Treatment of Moderate to Severe Acne Vulgaris,” Dow Pharmaceutical Sciences, Inc., 2007.

Marjan Yousefi, MD, Joseph R. Payne, MD, and Raymond Barnhill, MD (March 2006). Alopecia areata associated with regression of cutaneous melanoma. International Journal of Dermatology, 45 (3), 314-315.

“Patients Using MICRO Properly; An Open Label, Community Based, Phase Four Study to Assess Facial Acne Improvement with Use of RETIN-A MICRO® (Tretinoin Gel) Microsphere, 0.04% or 0.1% in a Pump Dispenser,” Johnson & Johnson CPW, 2006.

Clinical Research Trials and Publications (cont):

“Observational Post-Marketing Safety Surveillance Registry of Enbrel® (Etanercept) for the Treatment of Psoriasis,” Amgen, Inc., 2006.

“Clobex® Spray Community based Research Assessment (COBRA) Trial,” Galderma Laboratories, LP, 2006.

“A Randomized, Evaluator Blinded, Vehicle-Controlled Multi-Center Study of the Safety and Efficacy of 4% TRADENAME (Fluorouracil) Cream Versus Its Vehicle Versus Efudex® Cream in the Treatment of Actinic Keratosis,” Hill Dermaceuticals, Inc., 2006.

“Assessment and Tracking of Long-Term Alefacept Safety (ATLAS),” Biogen Idec, 2005.

“A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis,” Astellas Pharma, Inc., 2005.

“A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis (APPLES),” Astellas Pharma, Inc., 2005.

“KFD.C.005, A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of Ketaconazole Foam, 2%, versus Teva® (ketaconazole) 2% Cream in the Treatment of Seborrheic Dermatitis,” Connetics Corporation, 2005.

“Raptiva® Epidemiologic Study of Psoriasis Outcomes and Safety Events in Patients with Chronic Moderate to Severe Plaque Psoriasis (RESPONSE),” Genentech, 2005.

American Academy of Dermatology Summer Academy Meeting, New York, NY, July 31-August 4, 2002

American Academy of Dermatology 61st Annual Meeting, San Francisco, CA, March 21-25, 2003

Orlando Cosmetic Dermatology Convention, Orlando, FL, January 8-11, 2004

American Academy of Dermatology 62nd Annual Meeting, Washington, DC, February 6-11, 2004

National Naval Medical Center and Walter Reed Army Medical Center – Washington, DC Dermatological Society Clinical Conference, Washington, DC, March 23, 2004

Dave Barron Dermatopathology Seminar, Cincinnati, OH, April 15-16, 2004

American Academy of Dermatology 63rd Annual Meeting, New Orleans, LA, February 18-21, 2005

Uniformed Services Dermatology Seminar, Washington, DC, May 31-June 4, 2005

American Society for Mohs Surgery: Fundamentals of Mohs Surgery, San Diego, CA, November 10-13, 2005

American Academy of Dermatology 64th Annual Meeting, San Francisco, CA, March 3-7, 2006

American Society for Dermatologic Surgery Annual Meeting, Palm Desert, CA, October 26-28, 2006

American Academy of Dermatology 65th Annual Meeting, Washington, DC, February 2-6, 2007

American Society for Mohs Surgery 12th Annual Clinical Symposium, Santa Ana Pueblo, NM, May 25-27, 2007

American Academy of Dermatology 66th Annual Meeting, San Antonio, TX, January 31-February 5, 2008